Eyenovia Announces FDA Acceptance of IND Application for MicroPine to Reduce the Progression of Myopia
longevity investing Evolus Phase III European – Canadian Head-to-Head Trial of prabotulinumtoxinA Compared to Botox® Meets Primary Endpoint
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results
pharmaceutical investing ChemoCentryx Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Highlights
gold investing Newrange Gold Samples Up To 130 Grams Gold, Extends Merritt Zone And Begins Phase III Drilling At Pamlico
pharmaceutical investing Novartis receives FDA approval for Cosentyx label update to include moderate-to-severe scalp psoriasis
Newrange Gold Reports Last Drill Results for 2017 and Start of 2018 Drilling At Pamlico Gold Project, Nevada
QIMC Announces Closing of $17.3 Million Bought Deal Offering, Including Full Exercise of Underwriter's Over-Allotment Option
New Found Gold Closes Bought Deal Financing Including Full Exercise of Underwriters' Over-Allotment Option for Gross Proceeds of $115M
Couloir Capital Is Pleased to Announce That It Has Initiated Research Coverage on Pinnacle Silver and Gold
